About Us
Helping companies bring innovative diabetes and endocrine therapies to market faster.
Our team of dedicated and experienced clinical research staff have a track record of conducting world class research. Above all we pride ourselves on being meeting deliverables, while understanding the need to be adaptive, efficient, and approachable.
Edge Trials
Edge Trials was founded specifically to conduct commercial clinical research in diabetes and endocrinology - both in the device and medication fields. As an independent unit, we are flexible, and efficient, without compromising scientific integrity. Importantly, we conduct research across the lifespan, with our team having over a decade of experience in both paediatric and adult clinical trials.
We are located within the health precinct in Christchurch, New Zealand. Our team is strategically located alongside pharmacy, laboratory, radiology, inpatient and outpatient facilities. Our premises are modern and world class in order to meet the needs of commercial trials, including regulatory studies.
Meet The Team
Associate Professor Martin de Bock and Dr Renee Meier are the co-directors of Edge Trials, and between them add over 30 years of research experience.
Martin de Bock
Associate Professor Martin de Bock is a Paediatric Endocrinologist. He has 20 years of research experience in the diabetes and endocrinology field. He has over 130 peer reviewed publications, including the world leading journals like the New England Journal of Medicine. He has teaching and research roles at the University of Otago, and a clinical position in the department of paediatrics and child health, Christchurch hospital.
Renee Meier
Dr. Renee Meier is a registered dietitian with a PhD. She began her career in food science before transitioning into dietetics and diabetes research. For the past ten years, she has successfully managed clinical trials, enjoying the fast-paced environment, problem-solving, and challenges involved in delivering high-quality research outcomes.
Meet The Team
Associate Professor Martin de Bock and Dr Renee Meier are the co-directors of Edge Trials, and between them add over 30 years of research experience.
Martin de Bock
Associate Professor Martin de Bock is a Paediatric Endocrinologist. He has 20 years of research experience in the diabetes and endocrinology field. He has over 130 peer reviewed publications, including the world leading journals like the New England Journal of Medicine. He has teaching and research roles at the University of Otago, and a clinical position in the department of paediatrics and child health, Christchurch hospital.
Renee Meier
Dr. Renee Meier is a registered dietitian with a PhD. She began her career in food science before transitioning into dietetics and diabetes research. For the past ten years, she has successfully managed clinical trials, enjoying the fast-paced environment, problem-solving, and challenges involved in delivering high-quality research outcomes.
Why Work With Us
We are a dynamic, flexible, and highly experienced team.
Industry experience
Edge Trials researchers have considerable experience working with major international companies. We understand the importance of delivering milestones, and accountability. Above all, we are approachable and friendly, willing to adapt to the needs of industry sponsored trials.
Industry experience
Edge Trials researchers have considerable experience working with major international companies. We understand the importance of delivering milestones, and accountability. Above all, we are approachable and friendly, willing to adapt to the needs of industry sponsored trials.
Industry experience
Edge Trials researchers have considerable experience working with major international companies. We understand the importance of delivering milestones, and accountability. Above all, we are approachable and friendly, willing to adapt to the needs of industry sponsored trials.
Scientific integrity
We have a track record of conducting research for industry and investigator lead studies. The investigators have published in the highest ranked clinical trials – including the New England Journal of Medicine. We conduct studies at the highest possible standard with robust internal quality procedures.
Scientific integrity
We have a track record of conducting research for industry and investigator lead studies. The investigators have published in the highest ranked clinical trials – including the New England Journal of Medicine. We conduct studies at the highest possible standard with robust internal quality procedures.
Scientific integrity
We have a track record of conducting research for industry and investigator lead studies. The investigators have published in the highest ranked clinical trials – including the New England Journal of Medicine. We conduct studies at the highest possible standard with robust internal quality procedures.
Speed and precision
We pride ourselves on delivering outputs in a timely manner. Discuss your timelines with us, and see how we can accelerate your research and development pipeline.
Speed and precision
We pride ourselves on delivering outputs in a timely manner. Discuss your timelines with us, and see how we can accelerate your research and development pipeline.
Speed and precision
We pride ourselves on delivering outputs in a timely manner. Discuss your timelines with us, and see how we can accelerate your research and development pipeline.
Questions? Answers!
Find quick answers to the most common questions we're being asked.
How long does it take from research concept to first patient first visit?
This depends on how complete and/or complex the study protocol. Typically from first contact to first patient first visit, is approximately 12 weeks.
How does Edge Trials differ from other research providers?
We have a unique set of skills – from being able to write protocols, set up electronic research databases, to statistical analyses. We can provide for short feasibility studies, to large scale multi-centre pivotal studies. We can cover the lifespan – with both paediatric and adult experience. Further, New Zealand is uniquely positioned, where regulatory processes for conducting first in human studies are efficient, and we can therefore accelerate research programs.
Do timezone differences from NZ cause issues?
The team at Edge are highly flexible. Having worked with international sponsors for over a decade, we’ve never encountered time-zone issues.
Is Edge Trials a CRO?
Edge Trials is not a CRO, however, we conduct all study procedures commonly performed by CROs. Reach out and find out what we can offer for your needs.
Would you conduct studies outside the diabetes technology space?
Discuss your study with us. We don’t conduct phase I and II studies, but are co-located within a research precinct that does, and can likely connect your needs with others if we can’t provide the service for your study needs. Our health expertise is within diabetes and endocrinology.
Questions? Answers!
Find quick answers to the most common questions we're being asked.
How long does it take from research concept to first patient first visit?
How does Edge Trials differ from other research providers?
We have a unique set of skills – from being able to write protocols, set up electronic research databases, to statistical analyses. We can provide for short feasibility studies, to large scale multi-centre pivotal studies. We can cover the lifespan – with both paediatric and adult experience. Further, New Zealand is uniquely positioned, where regulatory processes for conducting first in human studies are efficient, and we can therefore accelerate research programs.
Do timezone differences from NZ cause issues?
The team at Edge are highly flexible. Having worked with international sponsors for over a decade, we’ve never encountered time-zone issues.
Is Edge Trials a CRO?
Edge Trials is not a CRO, however, we conduct all study procedures commonly performed by CROs. Reach out and find out what we can offer for your needs.
Would you conduct studies outside the diabetes technology space?
Discuss your study with us. We don’t conduct phase I and II studies, but are co-located within a research precinct that does, and can likely connect your needs with others if we can’t provide the service for your study needs. Our health expertise is within diabetes and endocrinology.
Questions? Answers!
Find quick answers to the most common questions we're being asked.
How long does it take from research concept to first patient first visit?
This depends on how complete and/or complex the study protocol. Typically from first contact to first patient first visit, is approximately 12 weeks.
How does Edge Trials differ from other research providers?
We have a unique set of skills – from being able to write protocols, set up electronic research databases, to statistical analyses. We can provide for short feasibility studies, to large scale multi-centre pivotal studies. We can cover the lifespan – with both paediatric and adult experience. Further, New Zealand is uniquely positioned, where regulatory processes for conducting first in human studies are efficient, and we can therefore accelerate research programs.
Do timezone differences from NZ cause issues?
The team at Edge are highly flexible. Having worked with international sponsors for over a decade, we’ve never encountered time-zone issues.
Is Edge Trials a CRO?
Edge Trials is not a CRO, however, we conduct all study procedures commonly performed by CROs. Reach out and find out what we can offer for your needs.
Would you conduct studies outside the diabetes technology space?
Discuss your study with us. We don’t conduct phase I and II studies, but are co-located within a research precinct that does, and can likely connect your needs with others if we can’t provide the service for your study needs. Our health expertise is within diabetes and endocrinology.
About Us
Helping companies bring innovative diabetes and endocrine therapies to market faster.
Our team of dedicated and experienced clinical research staff have a track record of conducting world class research. Above all we pride ourselves on being meeting deliverables, while understanding the need to be adaptive, efficient, and approachable.
Meet The Team
Associate Professor Martin de Bock and Dr Renee Meier are the co-directors of Edge Trials, and between them add over 30 years of research experience.
Martin de Bock
Associate Professor Martin de Bock is a Paediatric Endocrinologist. He has 20 years of research experience in the diabetes and endocrinology field. He has over 130 peer reviewed publications, including the world leading journals like the New England Journal of Medicine. He has teaching and research roles at the University of Otago, and a clinical position in the department of paediatrics and child health, Christchurch hospital.
Renee Meier
Dr. Renee Meier is a registered dietitian with a PhD. She began her career in food science before transitioning into dietetics and diabetes research. For the past ten years, she has successfully managed clinical trials, enjoying the fast-paced environment, problem-solving, and challenges involved in delivering high-quality research outcomes.